Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca May Face 6,000 Seroquel Trials as Judge to Urge Cases' Return
Bloomberg
Thursday, November 19, 2009 - 6:41am
tags:
AstraZeneca, Seroquel, diabetes, lawsuits
Drugmaker Reinvents Itself And Expands Footprint Internationally
Yahoo/Investors Business Daily
Thursday, November 19, 2009 - 6:40am
tags:
Valeant Pharmaceuticals, GSK
Four Healthcare Stocks On Fire
Investopedia
Thursday, November 19, 2009 - 6:38am
tags:
Novartis, Exelixis, Bristol-Myers Squibb, Sanofi, Intuitive Surgical
FDA panel backs Pfizer's enhanced vaccine for kids
Yahoo/AP
Thursday, November 19, 2009 - 6:37am
tags:
Pfizer, vaccines, pneumococcal disease, FDA, Panel, Prevnar
On the Radar: November's biotech stocks to watch
Fierce Biotech
Wednesday, November 18, 2009 - 12:17pm
tags:
biotech, Cadence Pharmaceuticals, Micromet, Momenta, Pharmasset, Protalix BioTherapeutics
Crestor shines, Vitamin D intrigues at AHA confab
Fierce Pharma
Wednesday, November 18, 2009 - 12:14pm
tags:
AHA, Crestor, AstraZeneca
Researchers will test Pfizer pipeline to find treatments for some tropical illnesses
Yahoo/AP
Wednesday, November 18, 2009 - 12:13pm
tags:
Pfizer, partnerships
GSK Takes Dow Jones to Task - on Its Blog
BNET Pharma
Wednesday, November 18, 2009 - 10:18am
tags:
GSK, Dow Jones, Teva Pharmaceuticals, Promacta
Good News for Alkermes' Pipeline
Yahoo/Zacks.com
Wednesday, November 18, 2009 - 10:15am
tags:
Alkermes, Amylin, Vivitrol
Biotech Stocks Hot Right Now, Ho-Hum in the Long Run
WSJ Online
Wednesday, November 18, 2009 - 10:13am
tags:
biotech, Talecris, deCODE Genetics
NicOx to Sell New Shares as FDA Agrees to Review Arthritis Drug
Bloomberg
Wednesday, November 18, 2009 - 9:33am
tags:
FDA, arthritis, stock offering, NicOx, naproxcinod
Another Genzyme Drug Goes Kaboom
TheStreet.com
Wednesday, November 18, 2009 - 9:09am
tags:
Genzyme, kidney disease, Renvela, APB
Drugmakers' Differences: Analyst's Toolkit
TheStreet.com
Wednesday, November 18, 2009 - 9:06am
tags:
Pfizer, Merck, GSK, Sanofi
Vivus Erection Drug Worked Within 30 Minutes in Study
Bloomberg
Wednesday, November 18, 2009 - 9:05am
tags:
erectile dysfunction, Vivus, Avanafil
Mead Johnson: This Poison Pill Aids Investors
NY Times, NY
Wednesday, November 18, 2009 - 9:03am
tags:
poison pill, investors, Bristol-Myers Squibb, Mead Johnson
Answering The Vytorin Question
Forbes
Wednesday, November 18, 2009 - 9:02am
tags:
Merck, Zetia, Vytorin, Abbott Laboratories, Niaspan, cholesterol
Crestor Cuts Cardiovascular Problems In Women
WSJ Online
Tuesday, November 17, 2009 - 5:27pm
tags:
AstraZeneca, women, Crestor, statins, JUPITER
Titan Pharmaceuticals: Finally Reaching Its Potential
Seeking Alpha
Tuesday, November 17, 2009 - 5:22pm
tags:
Titan
BioCryst hopes to raise $57M with stock offering
Bizjournals.com
Tuesday, November 17, 2009 - 4:07pm
tags:
Biocryst, stock offering
Oxigene's developing cancer treatment meets safety goals in midstage study
Yahoo/AP
Tuesday, November 17, 2009 - 2:17pm
tags:
Oxigene, drug studies, lung cancer, Zybrestat

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.